Drug Policy Watch · State Brief 2026

Texas

Snapshot (structured)

Adult-use cannabis: Not legal. No recreational market; possession remains criminal.
Medical cannabis: Legal but limited. Compassionate Use Program (TCUP), expanded by HB 46 (2025).
Home grow: Not permitted (no adult-use or patient cultivation).
Intoxicating hemp / hemp THC: Contested. Statute permits it; state rules and a closing federal window are squeezing it. Litigation ongoing.
Psychedelics: Decriminalization no. State-funded research yes (ibogaine and earlier psilocybin trials).
Broad decriminalization: No. Local decriminalization ordinances struck down by state courts.
Harm reduction: Limited. Naloxone widely available; syringe services legal only in a Bexar County carve-out; fentanyl test strips remain paraphernalia (any 2025 change unconfirmed as of June 2026).
Governor (party): Greg Abbott (Republican).
Legislature control: Republican in both chambers.
Citizen ballot initiatives allowed: No statewide citizen initiative process.
Enclosure pressure score: 4/5

Cannabis

Texas has no adult-use (recreational) cannabis. Possession of cannabis flower remains criminal: under 2 ounces is a Class B misdemeanor (up to 180 days jail and a $2,000 fine), 2 to 4 ounces is a Class A misdemeanor, and over 4 ounces is a felony. Concentrates are treated far more harshly, with less than 1 gram already a state jail felony. See the penalty summary at McCarty Larson (https://www.mccartylarson.com/marijuana-possession-in-texas/).

Medical access runs through the Compassionate Use Program (TCUP), administered by the Texas Department of Public Safety (DPS). In the 2025 regular session the legislature passed HB 46, which Governor Abbott signed on June 21, 2025, effective September 1, 2025. HB 46 added qualifying conditions (chronic pain lasting more than 90 days, Crohn's disease, traumatic brain injury, terminal illness, and hospice care), added delivery methods (lotions, patches, suppositories, and non-smoked pulmonary inhalation via DSHS-approved devices), replaced the old percentage cap with a 1 gram of THC per package limit, and raised the number of licensed dispensing organizations from three to fifteen while permitting satellite locations. Sources: MPP (https://www.mpp.org/states/texas/hb46-expands-compassionate-use-program/) and TexasCannabis.org (https://texascannabis.org/news-21jun2025).

Market structure: tightly licensed and vertically integrated. As of early 2026, three dispensing organizations were fully operational and additional applicants had received conditional approval through a two-phase DPS selection process, with Phase II conditional licensees announced by April 1, 2026, moving the program toward its statutory cap of fifteen licenses. Sources: DPS Phase II update (https://www.dps.texas.gov/news/dps-update-phase-ii-texas-compassionate-use-program-selection-process) and Community Impact (https://communityimpact.com/austin/central-austin/texas-legislature/2026/04/02/texas-tentatively-approves-3-new-dispensaries-for-medical-cannabis-program/). Patient registry numbers are tracked in the Compassionate Use Registry of Texas (CURT); a precise current enrollment figure is unconfirmed here.

Home grow is not permitted for any patient or adult.

Key 2026 actions: there is no 2026 regular session (Texas has a biennial legislature). Activity in 2026 is administrative (TCUP license rollout) and judicial (the hemp litigation below). The next regular session is the 90th Legislature, convening January 12, 2027.

Hemp

Texas law has permitted consumable hemp products since adopting the 2018 federal framework, and an estimated multibillion-dollar industry developed selling delta-8, delta-9 (from hemp), THCA flower, and similar products. Industry figures cite roughly 50,000 jobs and around 8,000 businesses. The state has spent 2025 and 2026 trying to curtail intoxicating hemp.

Legislative fight: In the 2025 regular session, Lt. Gov. Dan Patrick made a near-total THC ban his top priority. Senate Bill 3, authored by Sen. Charles Perry (R-Lubbock), would have banned consumable hemp with any amount of THC, leaving only CBD and CBG. The Senate passed it and the House sent it to the Governor, but Abbott vetoed SB 3 on June 22, 2025, citing likely unconstitutionality, conflict with federal law, and the example of a similar Arkansas ban blocked in federal court. Sources: Texas Tribune (https://www.texastribune.org/2025/06/22/texas-thc-ban-bill-greg-abbott-veto-senate-bill-3) and Cannabis Business Times (https://www.cannabisbusinesstimes.com/us-states/texas/news/15749075/texas-governor-vetoes-ban-on-hemp-products-calls-for-special-session-to-regulate-thc).

Abbott called special sessions to regulate rather than ban. In the July 2025 special session, the Senate passed SB 5 (Perry), again a broad THC ban with CBD/CBG carve-outs, on a 21-8 vote. The House did not pass it; a Democratic quorum break (over redistricting) stalled the chamber. Sources: Texas Tribune (https://www.texastribune.org/2025/07/30/texas-hemp-thc-senate-bill-5/) and MPP blog (https://blog.mpp.org/blog/texas-special-session-ban-on-hemp-derived-thc-passes-senate-heads-to-house/).

With the legislature deadlocked, Abbott shifted to executive and agency action. Executive Order GA-56 (issued September 10, 2025) directed DSHS, TABC, and DPS to use existing authority to keep hemp products from minors and to tighten rules. Source: Office of the Governor (https://gov.texas.gov/news/post/governor-abbott-issues-executive-order-to-protect-children-from-hemp-products). DSHS published proposed rules December 26, 2025, took over 1,400 comments, and adopted final rules effective March 31, 2026. The rules redefine total delta-9 THC to count convertible THCA (treating THCA as roughly 88 percent delta-9), effectively banning THCA flower, pre-rolls, and similar products, restrict interstate transport, and sharply raise license fees. TABC finalized companion rules for the consumable hemp industry in January 2026. Sources: Texas Tribune on TABC rules (https://www.texastribune.org/2026/01/20/texas-tabc-hemp-rules-finalized/), DSHS proposed rules in the Texas Register (https://www.sos.state.tx.us/texreg/archive/December262025/Proposed%20Rules/25.HEALTH%20SERVICES.html), and D8 Austin (https://www.d8austin.com/post/texas-smokable-hemp-ban-march-2026).

Litigation: A hemp industry coalition sued, arguing the agencies rewrote the statute. A Travis County judge granted a temporary restraining order, then a temporary injunction (reported around May 1, 2026) blocking the total-THC standard, with a trial on the merits set for July 27, 2026. The status has been volatile: in early June 2026 an appeals action put the smokable-hemp rule back in effect, with enforcement described as unclear. Sources: KUT (https://www.kut.org/business/2026-05-01/austin-tx-hemp-cannabis-ruling-temporary-injunction-granted-thca), KXAN (https://www.kxan.com/news/texas-politics/judge-bars-dshs-from-enforcing-new-hemp-rules-sets-late-july-trial-date/), and TPR (https://www.tpr.org/news/2026-06-09/texas-rule-targeting-smokable-hemp-is-back-in-effect). Because this is fast-moving, treat the exact enforcement posture as of June 16, 2026 as possibly stale; confirm against the live trackers below.

Federal exposure and the November 12, 2026 deadline: On November 12, 2025, the federal Continuing Appropriations and Extensions Act of 2026 closed the so-called hemp loophole by narrowing the federal hemp definition to total THC (capturing THCA, delta-8, delta-10, and other isomers) and limiting products to no more than 0.4 milligrams total THC per container, with the change taking effect November 12, 2026. Analysts estimate this could make a large majority of current hemp-derived intoxicating products federally illegal. This federal change largely accomplishes at the national level what Texas SB 3/SB 5 sought, and will land regardless of the Texas litigation. Sources: Regulatory Oversight (https://www.regulatoryoversight.com/2025/12/congress-narrows-federal-definition-of-hemp-effectively-banning-most-intoxicating-hemp-products/) and LAPPA (https://legislativeanalysis.org/closing-the-hemp-loophole-the-new-federal-definition-of-hemp-and-its-impact/).

Psychedelics

Texas has not decriminalized any psychedelic. Possession of psilocybin, ibogaine, and similar substances remains illegal under state law.

Texas is, however, a leader in state-funded psychedelic research. In June 2025 Abbott signed the Texas Ibogaine Initiative, described as the largest public investment in psychedelic research in U.S. history: HB 3717 (authored by Rep. Cody Harris) and the companion SB 2308 (sponsored by Sen. Tan Parker) authorize up to $50 million in state funding, matched by private money, for FDA-oriented clinical trials of ibogaine-assisted therapy for opioid and substance use disorders and other conditions, administered through the Health and Human Services Commission. This builds on HB 1802 (2021), which funded psilocybin trials for veterans with PTSD. Sources: Texas Public Radio (https://www.tpr.org/bioscience-medicine/2025-05-14/texas-house-passes-bill-to-fund-clinical-trials-studying-ibogaine-for-opioid-use-disorders-and-other-mental-health-conditions), LegiScan HB 3717 (https://legiscan.com/TX/text/HB3717/id/3152304), and American Homefront (https://americanhomefront.wunc.org/news/2025-07-14/texas-is-the-latest-state-to-embrace-psychedelic-therapy-research-for-mental-health).

2026 bills: with no 2026 regular session, no new psychedelic bills are pending. Implementation of the ibogaine grant program through HHSC is the live 2026 activity.

Broader drug policy

Decriminalization: Texas has not decriminalized drug possession. Local cannabis decriminalization ordinances passed by voters in 2022 (Austin, San Marcos, Killeen, Elgin, Denton) were challenged by Attorney General Ken Paxton in 2024 and have been struck down by state appeals courts in 2025 (see Ballot initiatives). Source: U.S. News (https://www.usnews.com/news/best-states/texas/articles/2025-04-25/state-appeals-court-strikes-down-austins-marijuana-decriminalization-ordinance).

Harm reduction: Naloxone (Narcan) access has expanded, including a state fentanyl awareness campaign and distribution to counties. Syringe services remain largely illegal statewide; the only sanctioned program operates under a Bexar County (San Antonio) carve-out, with other groups operating in legal gray areas, and federal harm-reduction funding came under pressure from a 2025 Trump executive order. Fentanyl test strips have repeatedly been classified as paraphernalia; the House passed legalization bills (for example HB 1644 in prior sessions, 145-0) but they stalled in the Senate. Whether any 2025 measure changed this is unconfirmed here; treat test strips as still restricted absent confirmation. Sources: San Antonio Report (https://sanantonioreport.org/needle-exchange-program-in-san-antonio-texas-at-risk-after-trump-order/), Texas Observer (https://www.texasobserver.org/fentanyl-test-strips-texas-legislature/), and KVUE (https://www.kvue.com/article/news/politics/texas-legislature/fentanyl-testing-strip-legalization-texas-house/269-ad881c3d-75d1-4e8d-a211-eb26f3a7c55a).

Sentencing and expungement: drug penalties remain among the strictest in the country. In 2025, SB 958 broadened expunction/nondisclosure eligibility to more controlled-substance misdemeanor convictions and deferred adjudications, and some reporting describes new automatic expungement for certain dismissed and acquitted cases. Sources: Wyde Law (https://www.wydelaw.com/the-impact-of-recent-texas-legislation-on-criminal-record-expungement-in-2025) and Texas Law Help (https://texaslawhelp.org/article/clear-or-seal-your-record-expunctions-vs-nondisclosures-in-texas).

Overdose and treatment: state response has centered on the fentanyl awareness campaign and naloxone distribution rather than on expanded syringe services or supervised-use models.

Political landscape

Governor: Greg Abbott (Republican). Lieutenant Governor and Senate president: Dan Patrick (Republican), who controls the Senate agenda. Speaker of the House: Dustin Burrows (R-Lubbock). Republicans hold majorities in both the 31-member Senate and the 150-member House. Source: 89th Texas Legislature (https://en.wikipedia.org/wiki/89th_Texas_Legislature).

On hemp/THC, the dividing lines are unusual and run within the GOP. Lead opponent of intoxicating hemp: Lt. Gov. Dan Patrick, who made a total ban his signature priority and publicly attacked Abbott's veto as de facto legalization. Bill sponsor for the ban: Sen. Charles Perry (R-Lubbock). On the other side, Gov. Abbott favored regulation over prohibition, vetoing SB 3 and pursuing agency rules and an executive order instead. Sources: Texas Tribune (https://www.texastribune.org/2025/06/23/texas-thc-ban-veto-dan-patrick-greg-abbott-sb-3/) and Texas Tribune veto coverage (https://www.texastribune.org/2025/06/22/texas-thc-ban-bill-greg-abbott-veto-senate-bill-3).

Reform-leaning figures include Rep. Cody Harris and Sen. Tan Parker on psychedelic research (a bipartisan, veteran-focused frame rather than a legalization frame). On the local-decriminalization side, U.S. Rep. Greg Casar (a former Austin council member) has criticized AG Paxton's lawsuits. Key committees for drug policy are unconfirmed by exact 2025-2027 membership here, but the relevant ones are the Senate State Affairs and Senate Criminal Justice committees (the latter has historically held harm-reduction bills) and the House Public Health and House Criminal Jurisprudence committees; confirm current chairs before citing.

Ballot initiatives

Texas has no statewide citizen-initiated ballot measure process; voters cannot put statutes or constitutional amendments on the ballot by petition. The only statewide ballot items are constitutional amendments referred by the legislature.

At the local level, several home-rule cities passed cannabis decriminalization ordinances by local initiative in 2022 (Austin, San Marcos, Killeen, Elgin, Denton). In January 2024, Attorney General Ken Paxton sued these cities, arguing the Local Government Code bars cities from declining to enforce drug laws. In 2025, a state appeals court ruled against the cities, striking down or blocking enforcement of the Austin and San Marcos ordinances, with the others on the same trajectory. Sources: KUT (https://www.kut.org/austin/2024-01-31/attorney-general-ken-paxton-austin-san-marcos-marijuana-possession-ordinances) and Community Impact (https://communityimpact.com/austin/south-central-austin/government/2025/04/24/appeals-court-sides-with-texas-in-challenge-to-austin-marijuana-decriminalization-ordinance/).

Equity and expungement

TCUP contains no social-equity licensing program; licenses are awarded through a competitive DPS process that favors well-capitalized vertically integrated operators, with no equity set-asides identified. There is no adult-use market and therefore no adult-use equity framework.

On records, Texas uses expunction (full erasure, generally for dismissals and acquittals) and orders of nondisclosure (sealing from public view, often after deferred adjudication). SB 958 (2025) expanded eligibility to more controlled-substance misdemeanor convictions and deferred adjudications, and reporting describes some automatic expungement for certain dismissed/acquitted cases. Relief is still largely petition-based and offense-limited, so many people with prior cannabis convictions, especially felonies and concentrate cases, remain excluded. Sources: Wyde Law (https://www.wydelaw.com/the-impact-of-recent-texas-legislation-on-criminal-record-expungement-in-2025), Collateral Consequences Resource Center (https://ccresourcecenter.org/state-restoration-profiles/texas-restoration-of-rights-pardon-expungement-sealing/), and Texas Law Help (https://texaslawhelp.org/article/clear-or-seal-your-record-expunctions-vs-nondisclosures-in-texas).

Market and barriers

Cannabis (TCUP): no adult-use tax exists. License cap is fifteen dispensing organizations statewide (raised from three by HB 46). Approximately three operators were fully licensed in early 2026 with additional conditional approvals pending toward the cap. The program is vertically integrated (cultivation, processing, dispensing under one license), which is capital-intensive; specific application and annual fee figures, and any residency or capital minimums, are unconfirmed here and should be verified against DPS TCUP rules. Sources: DPS (https://www.dps.texas.gov/news/dps-update-phase-ii-texas-compassionate-use-program-selection-process) and Vicente LLP TCUP overview (https://vicentellp.com/insights/texas-compassionate-use-program-tcup-overview/).

Hemp: the contested 2026 DSHS rules sharply increased license fees for growers, manufacturers, and retailers (exact dollar amounts unconfirmed here, pending the rule text and litigation outcome). The pre-rule market was large, with industry estimates of roughly 8,000 businesses and 50,000 jobs. Sources: D8 Austin (https://www.d8austin.com/post/texas-smokable-hemp-ban-march-2026) and Texas Hemp Business Council (https://texashempbusinesscouncil.com/legislative-update-governor-abbott-vetoes-sb-3/).

Enclosure read

Texas is consolidating on two fronts. In medical cannabis, the state runs a deliberately small, vertically integrated licensing regime (a hard cap of fifteen, no home grow, no equity tier) that fences out small operators and patients who might cultivate, and concentrates the legal market in a handful of well-funded firms. In hemp, the state and now the federal government are squeezing a large, decentralized industry of thousands of small retailers and farmers: the 2026 DSHS total-THC rule and the November 12, 2026 federal redefinition would together eliminate most intoxicating hemp products, pushing demand either out of the market or toward the narrow TCUP channel. Litigation has slowed but not reversed this. Who consolidates: the licensed TCUP operators and, to a degree, the prohibitionist political coalition led by the Lieutenant Governor. Who is fenced out: hemp small businesses, would-be home growers, patients outside TCUP's conditions, and people carrying drug records that remain hard to clear. The score is 4 rather than 5 because Abbott's veto and the courts have preserved a live (if shrinking) hemp market and HB 46 modestly widened legal medical access. Score: 4/5.

What to watch next

July 27, 2026: Travis County trial on the merits of the DSHS total-THC hemp rule (possible permanent injunction).
November 12, 2026: federal hemp redefinition (total THC, 0.4 mg per container) takes effect, likely outlawing most intoxicating hemp nationally.
November 9, 2026: bill filing opens for the 90th Legislature.
January 12, 2027: 90th Legislature convenes (runs through May 31, 2027); expect renewed THC ban and hemp-regulation fights and possible TCUP and harm-reduction bills.
Ongoing 2026: DPS completes TCUP license issuance toward the fifteen-license cap; HHSC stands up the ibogaine grant program.

Regulators

Texas Department of Public Safety (DPS): administers the Compassionate Use Program and the CURT registry; licenses dispensing organizations.
Texas Department of State Health Services (DSHS): regulates consumable hemp products and issued the 2026 total-THC rule.
Texas Alcoholic Beverage Commission (TABC): finalized hemp retail rules under GA-56 (January 2026).
Texas Health and Human Services Commission (HHSC): administers the ibogaine research grant program.
Texas Attorney General (Ken Paxton): litigation against local decriminalization ordinances.

Federal exposure (2026)

Texas sits at the sharp edge of every 2026 federal drug-policy lever, but one of them, the hemp cliff, dominates everything else here.

Rescheduling and 280E. Cannabis remains Schedule I by default. The DOJ/DEA order signed April 22, 2026 and effective April 28, 2026 (91 FR 22714) moved only FDA-approved cannabis drugs and state-licensed medical cannabis to Schedule III; recreational cannabis stays Schedule I. The practical federal effect for Texas is the end of Internal Revenue Code Section 280E (which bars ordinary business deductions for sellers of Schedule I and II substances) for the medical category only. Because Texas has no adult-use market and only a small, vertically integrated Compassionate Use Program (TCUP) capped at fifteen licenses, that 280E relief reaches just a handful of state-licensed medical operators, lowering their effective tax burden, while the much larger universe of hemp retailers and any would-be adult-use actors gets nothing. Schedule III does not legalize cannabis, does not authorize interstate commerce, and does not cover state-licensed businesses as such, so it changes the tax math for a few TCUP firms without opening the market. The read favors the existing incumbents.

The November 12, 2026 hemp cliff (critical for Texas). This is the single largest federal exposure in the state. Texas hosts one of the largest intoxicating-hemp markets in the country, with industry estimates of roughly 8,000 businesses and 50,000 jobs built on delta-8, delta-9 from hemp, THCA flower, and similar products. The FY2026 agriculture appropriations rider (Section 781, attributed in reporting to Rep. Andy Harris, R-MD; sponsor attribution unconfirmed, see https://www.regulatoryoversight.com/2025/12/congress-narrows-federal-definition-of-hemp-effectively-banning-most-intoxicating-hemp-products/) narrows the federal hemp definition to a total-THC standard of roughly 0.4 milligrams THC per container, recriminalizing an estimated 90 to 95 percent of intoxicating hemp products effective November 12, 2026. A proposed delay (reported as H.R.7010; bill number unconfirmed) was not enacted, and the 2026 Farm Bill (reported as H.R.7567; bill number unconfirmed, see Sources) keeps the ban in place.

The interaction with the Texas fight is what makes this acute. Texas has spent 2025 and 2026 trying to ban or sharply restrict the same products at the state level: Abbott vetoed the near-total ban (SB 3) on June 22, 2025, a revived ban (SB 5) died in the House during a quorum break, and the state then pivoted to a DSHS total-THC rule (effective March 31, 2026) that counts THCA toward the THC limit. That rule has been enjoined, then partly reinstated, with a trial on the merits set for July 27, 2026. The federal total-THC standard largely accomplishes at the national level what SB 3 and SB 5 sought, and it lands regardless of how the Texas litigation comes out. So even if the hemp coalition wins a permanent injunction against the DSHS rule in late July, the federal cliff arrives roughly three and a half months later and reaches the same products, including across state lines. The contested state fight, in other words, is being overtaken by a federal deadline that no Texas court can enjoin and no veto can stop. The federal enclosure read, which favors large incumbents and fences out small actors and hemp, falls hardest on exactly the decentralized Texas hemp industry.

Banking. SAFER Banking remains stalled in Congress, so state-legal cannabis operators (here, the TCUP licensees) still face limited access to mainstream banking and card networks. For Texas this is a smaller marginal issue than in adult-use states because the legal market is tiny, but it still raises costs for the few licensed medical operators and offers no relief to hemp businesses.

Psychedelics and the ibogaine interaction. Psilocybin, MDMA, and ibogaine all remain Schedule I federally. The April 18, 2026 executive order, Accelerating Medical Treatments for Serious Mental Illness [https://www.whitehouse.gov/presidential-actions/2026/04/accelerating-medical-treatments-for-serious-mental-illness/] plus FDA priority review vouchers fast-track FDA review of psychedelic therapies, but no psychedelic has been approved. This interacts directly with Texas policy: the state funds an up-to-50-million-dollar ibogaine research initiative (HB 3717, Rep. Cody Harris; companion SB 2308, Sen. Tan Parker, signed June 2025) aimed at FDA-oriented clinical trials for opioid and substance use disorders. The federal fast-track pathway is the channel through which Texas hopes its ibogaine investment converts into an approved medicine: state money funds the trials, but only the FDA can approve the drug and only federal rescheduling can move ibogaine off Schedule I. Texas has thus aligned its largest psychedelic bet with the federal medicalize-and-control approach, and its payoff depends on a federal process that has accelerated but not yet delivered an approval.

Harm reduction. The SAMHSA guidance of April 24, 2026 bars federal funds from paying for fentanyl test strips, clean syringes, and sterile water, while still supporting naloxone. The practical new effect in Texas is limited because Texas already bans fentanyl test strips as paraphernalia and already restricts syringe services to a single Bexar County carve-out, so the state was not relying on federal dollars to expand those services in the first place. The cut reinforces the existing state posture rather than changing it, and naloxone, the one tool Texas has actively expanded, remains federally supported.

Patient access and rights

This section covers what Texas law does and does not protect for a medical cannabis patient: use inside a hospital, and the broader rights that follow a patient into work, housing, parenting, an organ transplant list, and school. It is information, not legal advice, and it reflects the law as of July 2026. Each point links to the primary statute.

Texas has a limited medical cannabis program, not a comprehensive one. The Compassionate Use Program, expanded by House Bill 46 in 2025 (effective September 2025), lets qualifying patients obtain cannabis products for a defined set of conditions, which the 2025 law widened to add chronic pain lasting more than 90 days, Crohn's disease, traumatic brain injury, terminal illness, and hospice care. That law raised the old one-percent-THC-by-weight cap to a limit of 10 milligrams of THC per dose, allowed new product forms such as patches, lotions, and inhalers while still barring smoking, and expanded the program to fifteen licensed dispensers. It remains, by statute, a low-THC program, and a narrow one, and it comes with no patient protections attached.

Hospital access (Ryan's Law): Texas has no hospital-access law. No statute requires a hospital or similar facility to let a patient use medical cannabis on site, so the decision is left to each facility's own policy. Seven states have now enacted a Ryan's Law protection (California in 2021, and Colorado, Delaware, Louisiana, Oregon, Virginia, and Washington in 2026), with Pennsylvania's bill pending; Texas is not among them.

Broader protections: here the absence is the finding. A review of Texas law found no statutory protection for a medical cannabis patient in any of the areas other states cover: not employment, not housing, not a custody or visitation dispute, not placement on an organ transplant list, and not school enrollment, and there is no general medical-care protection. A Texas patient enrolled in the Compassionate Use Program still has no enforceable shield in these situations; the protection does not exist in state law today.

Out-of-state patients: Texas does not recognize other states' medical cannabis cards, and its Compassionate Use Program serves Texas patients only.

The federal picture: the April 2026 federal move of state-licensed medical cannabis to Schedule III did not change any of this. Schedule III does not make dispensary cannabis a lawful prescription medicine, and it creates no hospital-use right and no employment, housing, custody, transplant, or school protection; only state law can create those, and Texas has not.

Sources: the Texas Compassionate Use Program and House Bill 46 (2025).

Analysis: the enclosure read in depth

Who is fenced out in Texas. The state's structure forecloses commons-style access on almost every front. Medical cannabis runs through a deliberately small, vertically integrated TCUP regime: a hard cap of fifteen dispensing organizations, no home grow, no social-equity tier, and a capital-intensive single-license model (cultivation, processing, dispensing combined) that favors well-funded incumbents and excludes small operators and patients who might cultivate. The huge hemp industry, thousands of small retailers and farmers, is now caught in a vise between a state ban effort (Abbott veto notwithstanding, via the DSHS total-THC rule) and the federal November 12, 2026 cliff, with most of its product line slated to become illegal under both. Local democratic counter-moves have been shut down: the cannabis decriminalization ordinances voters passed in 2022 (Austin, San Marcos, Killeen, Elgin, Denton) were sued by AG Paxton and struck down by state appeals courts in 2025. And there is no structural escape valve, because Texas has no statewide citizen-initiative process (voters cannot petition statutes or amendments onto the ballot) and a biennial legislature with no 2026 regular session, so the next legislative window does not open until the 90th Legislature convenes January 12, 2027.

State-plus-federal interaction (the hemp cliff as the dominant force). The defining dynamic in Texas is that state and federal enclosure now point the same direction on hemp, and the federal lever is the stronger one. The state fight has been genuinely contested, an intra-GOP split between Lt. Gov. Patrick's prohibition drive and Gov. Abbott's regulate-not-ban stance, with the courts repeatedly intervening. But the federal total-THC standard renders much of that contest moot: it recriminalizes 90 to 95 percent of intoxicating hemp nationwide on November 12, 2026, reaches interstate commerce, and cannot be enjoined by a Texas court or vetoed by a Texas governor. A hemp-industry win at the July 27, 2026 state trial would buy only weeks before the federal deadline arrives. So the dominant force shaping the Texas market in late 2026 is federal, and it lands on the most decentralized, least-capitalized part of the state's drug economy, exactly the actors the federal enclosure read predicts will be fenced out in favor of large incumbents.

What to watch. The July 27, 2026 Travis County trial (whether the DSHS rule is permanently enjoined, and whether that matters given the federal date); the November 12, 2026 federal cliff itself and how Texas agencies (DSHS, TABC) choose to enforce against a market that federal law has just criminalized; whether any FDA action on ibogaine emerges from the federal fast-track to validate the state's 50-million-dollar bet; the completion of TCUP licensing toward the fifteen-license cap and whether 280E relief draws new capital into those slots; and the 90th Legislature in 2027, where renewed THC-ban, hemp-regulation, harm-reduction, and possible TCUP-expansion fights will play out.

Scarcity of commons counter-moves. There is very little room in Texas for bottom-up, decentralized, or equity-oriented responses. No citizen initiative means no ballot-box workaround; the AG litigation has closed the municipal-decriminalization route; the biennial calendar removes any 2026 legislative remedy; TCUP has no equity tier or home grow; and harm-reduction tools (test strips, syringe services) remain banned or boxed into one county. The few openings are top-down and incumbent-friendly: 280E relief for the handful of medical licensees, and a state-funded, FDA-routed ibogaine research program. Both medicalize and control rather than open access.

Justifying the enclosure score (4/5). The score is high because nearly every vector points toward consolidation: a capped, vertically integrated medical regime; a hemp industry about to be gutted by a federal ban the state was already trying to impose; no citizen initiative; litigation killing local reform; and harm-reduction restrictions reinforced by federal funding cuts. It is held at 4 rather than 5 because two genuine, if narrow, counter-pressures survive: Abbott's veto and the courts have kept a live (though shrinking and federally doomed) hemp market open into late 2026, and HB 46 modestly widened legal medical access while the new 280E relief lowers costs for licensed operators. Those are real but incumbent-tilted openings, not a commons, so the pressure stays at 4/5.

Active legislation (2026)

Texas has a biennial legislature with no 2026 regular session, so there are no pending 2026 regular-session bills. The items below are the significant recent measures from the 2025 regular and special sessions that define the current (2026) policy landscape, plus the 2026 administrative and judicial actions carrying them forward. This list is not exhaustive; see the live trackers noted after the table.

Beyond the live tracker

These major Texas actions are not in the live bill list below: two are not bills (an executive order and an agency rule), and one is an enacted bill the tracker does not currently surface.

Executive Order GA-56 (issued Sept 10, 2025): directs DSHS, TABC, and DPS to restrict hemp to minors and tighten rules.
DSHS Total THC Rule (effective March 31, 2026; enjoined, then partly back in effect, trial July 27, 2026): counts THCA toward the THC limit and bans smokable/THCA hemp.
SB 958 (enacted 2025): expanded expunction and nondisclosure for drug offenses.

Bill	Title/Topic	Chamber	Status	Sponsor(s)
HB 46 (2025)	TCUP medical cannabis expansion (conditions, delivery, 15 licenses)	House (passed both)	Signed June 21, 2025; effective Sept 1, 2025	Lead author unconfirmed
SB 3 (2025)	Near-total ban on consumable hemp THC	Senate (passed both)	Vetoed by Abbott June 22, 2025	Sen. Charles Perry
SB 5 (2025 special)	Revived broad THC ban (CBD/CBG carve-out)	Senate	Passed Senate 21-8; died in House (quorum break)	Sen. Charles Perry
HB 3717 (2025)	Texas Ibogaine Initiative research grants	House (passed both)	Signed by Abbott June 2025	Rep. Cody Harris
SB 2308 (2025)	Companion to ibogaine research initiative	Senate	Enacted as part of ibogaine initiative	Sen. Tan Parker
SB 958 (2025)	Expanded expunction/nondisclosure for drug offenses	Senate	Enacted (2025)	Unconfirmed
HB 1644 (prior session)	Legalize fentanyl/xylazine test strips	House	Passed House; stalled in Senate; 2025 status unconfirmed	Unconfirmed
Executive Order GA-56 (2025)	Directs DSHS/TABC/DPS to restrict hemp to minors, tighten rules	Executive	Issued Sept 10, 2025	Gov. Greg Abbott
DSHS Total THC Rule (2026)	Counts THCA toward THC limit; bans smokable/THCA hemp	Agency rule	Effective March 31, 2026; enjoined, then partly back in effect; trial July 27, 2026	DSHS / HHSC

Live trackers (long tail, authoritative): LegiScan Texas (https://legiscan.com/TX), Texas Legislature Online (https://capitol.texas.gov/), and Marijuana Moment Texas coverage (https://www.marijuanamoment.net/?s=texas).

Support this work

This work is free and reader-funded. No paywalls, no ads. This brief is independent and fully sourced, and reader contributions are what keep the 50-state coverage current and answerable to readers, not advertisers or owners.

If it helped you, please chip in $5 to keep it going. Recurring support helps most; about $25 funds a full refresh of a state brief like this one.

Contribute $5 on Ko-fi Become a member

← Back to all 50 states and federal briefs

A planning snapshot for 2026, not legal advice. Policy moves quickly; confirm any single detail against the cited sources before acting on it. Sponsor names are given where confirmable and marked unconfirmed otherwise.

About the author. Jessica Mantonya is the founder of Drug Policy Watch and Hold in Common. She also advises operators, advocates, and funders on regulatory strategy and anti-enclosure positioning. Work with her →